Literature DB >> 25366322

Micro-RNAs meet epigenetics to make for better brains.

Florian Noack1, Federico Calegari1.   

Abstract

Recent studies have highlighted the importance of regulatory non‐coding RNAs and epigenetics in controlling the differentiation of somatic stem cells. Two major pathways characterize these fields: micro‐RNAs (miRNAs) and DNA methylation. In this issue of EMBO Reports, Lv et al show that during mammalian corticogenesis, miR‐15b inhibits cytosine demethylation by targeting Tet3, a key methylcytosine dioxygenase. This leads to the epigenetic downregulation of cyclin D1. As a result, cell cycle and differentiation of neural progenitors are altered, promoting their switch to neurogenesis. Hence, Lv et al elegantly bring together miRNAs and DNA methylation in the cell cycle control of neural progenitors and neurogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25366322      PMCID: PMC4264922          DOI: 10.15252/embr.201439682

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  9 in total

1.  MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling.

Authors:  Laura Poliseno; Min Sup Song; Su Jung Song; Ugo Ala; Kaitlyn Webster; Christopher Ng; Gary Beringer; Nicolai J Brikbak; Xin Yuan; Lewis C Cantley; Andrea L Richardson; Pier Paolo Pandolfi
Journal:  Cell       Date:  2013-07-03       Impact factor: 41.582

Review 2.  MicroRNAs potentiate neural development.

Authors:  Sarah K Fineberg; Kenneth S Kosik; Beverly L Davidson
Journal:  Neuron       Date:  2009-11-12       Impact factor: 17.173

3.  An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis.

Authors:  Jijun Cheng; Shangqin Guo; Suning Chen; Stephen J Mastriano; Chaochun Liu; Ana C D'Alessio; Eriona Hysolli; Yanwen Guo; Hong Yao; Cynthia M Megyola; Dan Li; Jun Liu; Wen Pan; Christine A Roden; Xiao-Ling Zhou; Kartoosh Heydari; Jianjun Chen; In-Hyun Park; Ye Ding; Yi Zhang; Jun Lu
Journal:  Cell Rep       Date:  2013-10-10       Impact factor: 9.423

Review 4.  MicroRNAs and epigenetics.

Authors:  Fumiaki Sato; Soken Tsuchiya; Stephen J Meltzer; Kazuharu Shimizu
Journal:  FEBS J       Date:  2011-03-30       Impact factor: 5.542

5.  MicroRNA-26a targets ten eleven translocation enzymes and is regulated during pancreatic cell differentiation.

Authors:  Xianghui Fu; Liang Jin; Xichun Wang; Angela Luo; Junkai Hu; Xianwu Zheng; Walter M Tsark; Arthur D Riggs; Hsun Teresa Ku; Wendong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-10       Impact factor: 11.205

6.  MicroRNA-15b promotes neurogenesis and inhibits neural progenitor proliferation by directly repressing TET3 during early neocortical development.

Authors:  Xiaohui Lv; Huihui Jiang; Yanli Liu; Xuepei Lei; Jianwei Jiao
Journal:  EMBO Rep       Date:  2014-10-24       Impact factor: 8.807

Review 7.  DNA methylation and methylcytosine oxidation in cell fate decisions.

Authors:  Kian Peng Koh; Anjana Rao
Journal:  Curr Opin Cell Biol       Date:  2013-03-14       Impact factor: 8.382

8.  Mechanisms of brain evolution: regulation of neural progenitor cell diversity and cell cycle length.

Authors:  Victor Borrell; Federico Calegari
Journal:  Neurosci Res       Date:  2014-04-28       Impact factor: 3.304

9.  MiR-15b targets cyclin D1 to regulate proliferation and apoptosis in glioma cells.

Authors:  Guan Sun; Lei Shi; Shushan Yan; Zhengqiang Wan; Nan Jiang; Linshan Fu; Min Li; Jun Guo
Journal:  Biomed Res Int       Date:  2014-06-04       Impact factor: 3.411

  9 in total
  2 in total

1.  Differential Expression of miRNAs and Their Predicted Target Pathways in Cochlear Nucleus Following Chronic Noise Exposure in Rats.

Authors:  Chang Ho Lee; Jiwon Jeon; So Min Lee; So Young Kim
Journal:  Cells       Date:  2022-07-22       Impact factor: 7.666

2.  Identification and validation of mRNA 3'untranslated regions of DNMT3B and TET3 as novel competing endogenous RNAs of the tumor suppressor PTEN.

Authors:  Kenneth Anthony R Roquid; Krizelle Mae M Alcantara; Reynaldo L Garcia
Journal:  Int J Oncol       Date:  2019-12-20       Impact factor: 5.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.